the united republic of tanzania health sector hiv and aids strategic plan
the united republic of tanzania health sector hiv and aids strategic plan the united republic of tanzania health sector hiv and aids strategic plan
4.0.SECTION FOUR: ANNEXES ANNEX 1: SELECTED UNIT COSTS FROM MKUKUTA BASED MDGS COSTINGS FOR THE HEALTH SUB-SECTOR “Mkukuta Based MDGs Costings for the Health Sub-sector” Unit costs used for HIV and AIDS interventions Subdivision or Thematic area Prevention Treatment, care and support Intervention, strategy or health service Reduction of stigma and discrimination of PLHIV Promotion of safer Sex 70 |FINAL COMBINED-HSHSP 2008-2012: June 24 th 2007 Activity Cost component Cost per case/Unit costs Awareness creation and sensitisation of general public through media Radio and TV programmes (US$) Percentage of Reference in need 0.45 10% of total population Procurement and Supplies 1.15 60% of sexually distribution of male condoms active pop. Procurement and distribution of female condoms Supplies VCT Procurement and Reagents and 4.57 Fixed quantity of distribution of reagents and supplies to test sero 600,000 other medical supplies positive Reagents and 6.18 Fixed quantity of supplies to test sero negative 60,000 Training of counsellors Supplies and 2033.33 Fixed quantity of allowances 210 Safe blood Safe blood transmission Supplies 14.53 PMTCT PMTCT Drugs and supplies 54.93 Number of births 8.80% Prevention of Opthalmia Drugs and supplies 0.02 Number of births Neonatorum 100% Treatment of Neonatal Drugs and supplies 26.05 Number of births Complications (LBW, Sepsis, etc) 10.00% Prevention of Chlamydia Drugs and supplies 0.97 1.23% of Women in sexual transmission (STIs, reproductive age Care and treatment Gonorrhoea Drugs and supplies 0.56 6.29% of Women in reproductive age Syphilis Drugs and supplies 2.77 5.86% of Women in reproductive age Trichomoniasis Drugs and supplies 0.63 11.34% of Women in reproductive age Pelvic inflammatory disease Drugs and supplies 0.64 2.53% of Women in HSV 2 Provide Antiretroviral drugs to adults, 1 st line Provide Antiretroviral drugs to adults, 2 nd line Provide Antiretroviral drugs to children, 1 st line Provide Antiretroviral drugs to children, 2 nd line reproductive age Drugs and supplies 370.52 Fixed quantity 88,200 Drugs and supplies 3661.54 Fixed quantity 1,800 Drugs and supplies 955.80 Fixed quantity 800 Drugs and supplies 5576.68 Fixed quantity 200
“Mkukuta Based MDGs Costings for the Health Sub-sector” –Unit Costs for Health system Subdivision or Thematic area Intervention, strategy or health service Health facilities Strengthening health infrastructure Human resources (Dispensary, Health centre, District , Regional and Ref. hospitals) Capacity building for human resources for health to have the correct skill mix in place (quantity and quality wise) Strengthen management capacity Strengthening MOHSW training centres (including zonal training centres) Capacity building for health systems research Management at the Ministry of Health and Social Welfare 71 |FINAL COMBINED-HSHSP 2008-2012: June 24 th 2007 Activity Cost component Cost per case/Unit Construction Rehabilitation Upgrading Renewal Operation and maintenance Buildings Instruments and equipment Furniture Communication devices and IT Transport Electricity and water Hiring and Pay package retention Relocation Allowances In service training School fee/fare/allowance Attendance of Allowance/fare international meetings Hiring and Pay package retention Relocation Allowance In service training Teaching mat./fare/fee/allowance Linking health Allowance/fare system with the community Provision of IT/furniture equipment Rehabilitation Buildings Installation of IT Medical equipment Hiring and Teaching equipment retention Furniture In service training IT Operations and Pay package maintenance Utilities Communication Provision of funds Per diem Provision of technical assistance All costs (US$) Percentage of existing health facilities requiring rehabilitation Buildings 50% Instruments and equipment 100% Furniture 100% Communication 100% Transport 100%
- Page 19 and 20: 1.2.3.2. Financial Contributions to
- Page 21 and 22: Decentralisation: Devolution of key
- Page 23 and 24: Achievements Currently 659 sites (
- Page 25 and 26: Indicators Number of health instit
- Page 27 and 28: Key implementers Referral, regiona
- Page 29 and 30: Indicator % of blood units transfu
- Page 31 and 32: etween older males and girls. On th
- Page 33 and 34: Challenges Aspects Challenges for p
- Page 35 and 36: Aspects Challenges for Facility Bas
- Page 37 and 38: Key implementers MoHSW, Private ho
- Page 39 and 40: ased care services Establish mecha
- Page 41 and 42: Challenges Aspects Challenges for L
- Page 43 and 44: Emerging Issues Private for profit
- Page 45 and 46: B. Information Education and Commun
- Page 47 and 48: Challenges Aspects Challenges in Co
- Page 49 and 50: delivery of all health programmes-
- Page 51 and 52: o Coordinate partnerships between e
- Page 53 and 54: Pharmacovigilance and quality assur
- Page 55 and 56: o The tendency of recruitment of st
- Page 57 and 58: Availability of annual, midterm and
- Page 59 and 60: Key Implementers MoHSW, Academic I
- Page 61 and 62: 3.0. SECTION THREE IMPLEMENTATION F
- Page 63 and 64: plan for districts. Rather the acti
- Page 65 and 66: The Table 14 below shows the trend
- Page 67 and 68: Given the findings discussed above
- Page 69: Monitoring Depending on the type an
- Page 73 and 74: ANNEX 2: FRAMEWORK FOR TARGET SETTI
- Page 75 and 76: ANNEX 3: ORGANOGRAM OF MINSTRY OF H
- Page 77 and 78: Strategy 4: Improve programme manag
- Page 79 and 80: Intervention Area 3a: Prevention of
- Page 81 and 82: Intervention Area 4a: Vulnerable Po
- Page 83 and 84: Intervention Area 5: Positive Preve
- Page 85 and 86: Strategy 3: Increase access to and
- Page 87 and 88: Strategy 4: To reduce the burden of
- Page 89 and 90: Intervention area 2: Community base
- Page 91 and 92: Strategy 3: Develop and implement c
- Page 93 and 94: Strategy 3: Develop effective strat
- Page 95 and 96: Strategy 1: To ensure nation-wide a
- Page 97 and 98: Strategy 3: Implement and strengthe
- Page 99 and 100: Strategy 1: Strengthen existing and
- Page 101 and 102: Intervention area 3: Promote BCC pr
- Page 103 and 104: 103 |FINAL COMBINED-HSHSP 2008-2012
- Page 105 and 106: Intervention area 3: Human Resource
- Page 107 and 108: Intervention area 4: Strategic info
- Page 109 and 110: Strategic Objectives 3: To strength
- Page 111: ANNEX 5: REFERENCE AND NOTES i TACA
4.0.SECTION FOUR:<br />
ANNEXES<br />
ANNEX 1: SELECTED UNIT COSTS FROM MKUKUTA BASED MDGS<br />
COSTINGS FOR THE HEALTH SUB-SECTOR<br />
“Mkukuta Based MDGs Costings for <strong>the</strong> Health Sub-<strong>sector</strong>” Unit costs used for HIV <strong>and</strong> AIDS<br />
interventions<br />
Subdivision<br />
or Thematic<br />
area<br />
Prevention<br />
Treatment,<br />
care <strong>and</strong><br />
support<br />
Intervention,<br />
strategy or<br />
<strong>health</strong> service<br />
Reduction <strong>of</strong><br />
stigma <strong>and</strong><br />
discrimination <strong>of</strong><br />
PLHIV<br />
Promotion <strong>of</strong><br />
safer Sex<br />
70 |FINAL COMBINED-HSHSP 2008-2012: June 24 th 2007<br />
Activity Cost component Cost per<br />
case/Unit costs<br />
Awareness creation <strong>and</strong><br />
sensitisation <strong>of</strong> general<br />
public through media<br />
Radio <strong>and</strong> TV<br />
programmes<br />
(US$)<br />
Percentage <strong>of</strong><br />
Reference in need<br />
0.45 10% <strong>of</strong> total<br />
population<br />
Procurement <strong>and</strong><br />
Supplies 1.15 60% <strong>of</strong> sexually<br />
distribution <strong>of</strong> male condoms<br />
active pop.<br />
Procurement <strong>and</strong><br />
distribution <strong>of</strong> female<br />
condoms<br />
Supplies<br />
VCT<br />
Procurement <strong>and</strong><br />
Reagents <strong>and</strong> 4.57 Fixed quantity <strong>of</strong><br />
distribution <strong>of</strong> reagents <strong>and</strong> supplies to test sero<br />
600,000<br />
o<strong>the</strong>r medical supplies positive<br />
Reagents <strong>and</strong> 6.18 Fixed quantity <strong>of</strong><br />
supplies to test sero<br />
negative<br />
60,000<br />
Training <strong>of</strong> counsellors Supplies <strong>and</strong> 2033.33 Fixed quantity <strong>of</strong><br />
allowances<br />
210<br />
Safe blood Safe blood transmission Supplies 14.53<br />
PMTCT<br />
PMTCT Drugs <strong>and</strong> supplies 54.93 Number <strong>of</strong> births<br />
8.80%<br />
Prevention <strong>of</strong> Opthalmia Drugs <strong>and</strong> supplies 0.02 Number <strong>of</strong> births<br />
Neonatorum<br />
100%<br />
Treatment <strong>of</strong> Neonatal Drugs <strong>and</strong> supplies 26.05 Number <strong>of</strong> births<br />
Complications (LBW,<br />
Sepsis, etc)<br />
10.00%<br />
Prevention <strong>of</strong> Chlamydia Drugs <strong>and</strong> supplies 0.97 1.23% <strong>of</strong> Women in<br />
sexual<br />
transmission<br />
(STIs,<br />
reproductive age<br />
Care <strong>and</strong><br />
treatment<br />
Gonorrhoea Drugs <strong>and</strong> supplies 0.56 6.29% <strong>of</strong> Women in<br />
reproductive age<br />
Syphilis Drugs <strong>and</strong> supplies 2.77 5.86% <strong>of</strong> Women in<br />
reproductive age<br />
Trichomoniasis Drugs <strong>and</strong> supplies 0.63 11.34% <strong>of</strong> Women<br />
in reproductive age<br />
Pelvic inflammatory disease Drugs <strong>and</strong> supplies 0.64 2.53% <strong>of</strong> Women in<br />
HSV 2<br />
Provide Antiretroviral drugs<br />
to adults, 1 st line<br />
Provide Antiretroviral drugs<br />
to adults, 2 nd line<br />
Provide Antiretroviral drugs<br />
to children, 1 st line<br />
Provide Antiretroviral drugs<br />
to children, 2 nd line<br />
reproductive age<br />
Drugs <strong>and</strong> supplies 370.52 Fixed quantity<br />
88,200<br />
Drugs <strong>and</strong> supplies 3661.54 Fixed quantity<br />
1,800<br />
Drugs <strong>and</strong> supplies 955.80 Fixed quantity 800<br />
Drugs <strong>and</strong> supplies 5576.68 Fixed quantity 200
Change language